Matthew F. Gorman
Kaiser Permanente Santa Clara Medical Center(US)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Chronic Myeloid Leukemia Treatments, Myeloproliferative Neoplasms: Diagnosis and Treatment, Erythrocyte Function and Pathophysiology
Most-Cited Works
- → Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras(2009)149 cited
- → Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): A therapeutic advances in childhood leukemia (TACL) consortium study(2010)112 cited
- → A MEK Inhibitor Abrogates Myeloproliferative Disease in Kras Mutant Mice(2011)91 cited
- → The Spectrum of SPTA1-Associated Hereditary Spherocytosis(2019)56 cited
- → A clofarabine-based bridging regimen in patients with relapsed ALL and persistent minimal residual disease (MRD)(2013)13 cited
- → Corrigendum: The Spectrum of SPTA1-Associated Hereditary Spherocytosis(2019)9 cited
- → Mutations That Cooperate with Nf1 Inactivation in Leukemogenesis Influence Therapeutic Response to MEK Inhibition.(2007)4 cited
- → Retrospective analysis of children treated for relapsed acute myelogenous leukemia (rAML): A report from the Therapeutic Advances in Childhood Leukemia (TACL) Consortium(2008)1 cited
- → Langerhans' Cell Histiocytosis(2008)
- → Evaluation of Patients with Bleeding Symptoms Using a Novel Perfusion Chamber Assay (PCA)(2012)